🟢 Decoy Therapeutics is trading 12.58% up in after-hours trading after announcing a pan-filovirus antiviral program

Decoy Therapeutics is trading 12.58% up at $3.49 after announcing a pan-filovirus antiviral program targeting Ebola and Marburg viruses through the FDA’s Animal Rule pathway.

• A first-generation candidate showed low-micromolar activity against wild-type Ebola Zaire and activity against Marburg.
• The company is pursuing non-dilutive funding and potential Priority Review Voucher eligibility.